Clinical Trial Update: ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ABCB1/P-glycoprotein expression as a biomarker to stratify patients with non-metastatic osteosarcoma; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Snippet

Sponsor: Italian Sarcoma Group | Conditions: Osteosarcoma | Phase 2 | Status: COMPLETED